For patients with eosinophilic esophagitis, eating can become an exercise in calculated risk rather than a simple pleasure. For Eupraxia Pharmaceuticals Inc. (NASDAQ: EPRX; TSX: EPRX), that burden represents both an urgent medical problem and a potentially compelling opportunity to prove that…
FIGS, Inc. (NYSE: FIGS) just delivered the kind of quarter that reminds investors why “boring” healthcare can quietly become a growth stock thriller—no meme magic required, just rising margins, disciplined execution, and a growing global tribe of loyal customers.
Healthcare Couture Gets…
Doximity, Inc. (NYSE: DOCS) shares sold off into the close today but then staged a sharp rebound in the after‑hours session, with the stock surging more than 60 percent off its regular‑session levels as investors reassessed the company’s fiscal 2027 first‑quarter results…
Amwell (NYSE: AMWL) is trying to do something rare in healthcare technology: become more interesting by becoming less dramatic. After years of telehealth hype, backlash, and normalization, the company’s latest setup suggests a business leaning into discipline, enterprise relevance, and just enough…
If the first wave of AI was about raw horsepower, the next wave is looking more like a procurement decision. Reed Hastings’ TED conversation (below) about AI’s accelerating importance underscores the scale of the opportunity, but the real market question is now…
Knightscope’s (KSCP) latest video (below) with CEO & Founder William Santana Li fits a market that is still early, still messy, and still very big — which is exactly why the bullish case could have room to run. The company is pitching…
In the bustling digital amphitheater of Tribe Public’s latest CEO Presentation, the question of the hour was as sharp as it was timely: “Is the beaten down biotech sector the smartest bet in today’s volatile market?” With a flourish of slides and…
